WARD Surgery

WARD Surgery

Principal Investigator

Camilla Haahr-Raunkjær, MD, PhD student

Study design
Prospective study/cohort
Sample size
505 participants
Study sites

Bispebjerg Hospital and Rigshospitalet

Inclusion criteria
  • Patient > 60 years old
  • Elective operation performed at Bispebjerg Hospital or Rigshospitalet.
  • Elective major abdominal cancer surgery.
  • Operation estimated to last more than 2 hours.
Study procedures

Wearable devices recorded heart rate, breathing rate and oxygen saturation for up to 96 hours on the surgical ward. Blood pressure was measured at intervals. Staff and patients could not see the research readings. Complications were assessed after surgery.

Results

Serious adverse events occurred in 37% of patients, with 38% occurring during monitoring. Among patients with SAE during monitoring, the median duration of vital sign abnormalities was 272 min (IQR 110-447), compared to 259 min (IQR 153-394) in patients with SAE after monitoring and 261 min (IQR 132-468) in the patients without any SAE (p = .62 for all three group comparisons). Episodes of heart rate ≥110 bpm occurred in 16%, 7.1%, and 3.9% of patients in the time before SAE during monitoring, after monitoring, and without SAE, respectively (p < .002). Patients with SAE after monitoring experienced more episodes of hypotension ≤90 mm Hg/24 h (p = .001).

Outcome

The total time spent beyond predefined vital sign thresholds was not associated with serious adverse events. Episodes of low blood pressure and rapid heart rate were more common before serious adverse events.

Trial registration
NCT03491137

–  Read more